Milla continues as a Clinical Research Fellow in Unscheduled Care Flow at Imperial College London. She has also accepted a position as Principal at GrayBella Capital, launching a 1100 million venture capital fund investing in series A&B financings, in healthcare and technology companies across Europe.
